Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model

ConclusionThe loweredC. jejuni loads and alleviated symptoms observed in the here applied clinical murine model for human campylobacteriosis highlight the application of carvacrol as a promising novel option for both, the treatment of campylobacteriosis and hence, for prevention of post-infectious sequelae in humans, and for the reduction ofC. jejuni colonization in the intestines of vertebrate lifestock animals.

http://link.springer.com/10.1186/s13099-019-0343-4

Source: Gut Pathogens - January 7, 2020 Category: Microbiology Source Type: research